CLVS
These four companies could be among the next stocks that the Reddit retail army goes after. Their stocks have solid Buy ratings at major Wall Street firms, and could really take off with positive...
Published:
Last Updated:
Wednesday's top analyst upgrades, downgrades and initiations included Agilent Technologies, American Power, Apache, Boeing, Ciena, Cisco, FireEye, Palo Alto Networks, Sony, Southwest Airlines and...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Apple, Blackstone, CBS, Global Payments, Netflix, Ralph Lauren, Walt Disney and Wynn Resorts.
Published:
The top analyst upgrades, downgrades and initiations on Tuesday included Advanced Micro Devices, Apple, Barrick Gold, Domino's Pizza, Intel, McDonald's, Occidental Petroleum and Salesforce.com.
Published:
The top analyst upgrades, downgrades and initiations seen on Friday included Shopify, Qualcomm, Pinterest, Sprouts Farmer's Market, BlackLine, Fortinet and Carbon Black.
Published:
Clovis Oncology may have thought that it could sneak an announcement by late on Friday, but its shares were definitely paying the price Monday morning.
Published:
Last Updated:
Clovis Oncology shares jumped on Tuesday after the European Patent Office upheld the company’s claims.
Published:
Last Updated:
IBM, General Electric, McDermott International, and Clovis Oncology all posted new 52-week lows Wednesday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aetna, Baker Hughes, Chesapeake Energy, Cognizant Technology Solutions, Cummins, Eli Lilly, General Electric, Qualcomm...
Published:
Last Updated:
Keycorp, eBay, Schlumberger, and Clovis Oncology all posted new 52-week lows Monday.
Published:
Last Updated:
Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca at the ESMO 2018 Congress.
Published:
Last Updated:
Clovis Oncology shares jumped on Tuesday after the U.S. Food and Drug Administration (FDA) gave a critical update.
Published:
Last Updated:
Clovis shares might not be showing it now, but the company is facing some heat from the SEC over charges of misleading investors about the company’s developmental lung cancer drug.
Published:
Last Updated:
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Published:
Last Updated:
Clovis Oncology shares saw a bump early on Thursday after the company announced that the European Medicines Agency has validated its application for a Type 2 variation to the marketing authorization...
Published:
Last Updated: